Biodesix Inc. (BDSX) Tops Q2 EPS by 1c ; Offers Guidance

Biodesix Inc. (NASDAQ: BDSX) reported Q2 EPS of ($0.08), $0.01 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $17.9 million versus the consensus estimate of $16.12 million.

GUIDANCE:

Biodesix Inc. sees FY2024 revenue of $70-72 million, versus the consensus of $66.98 million.

For earnings history and earnings-related data on Biodesix Inc. (BDSX) click here.

You May Also Be Interested In

• Carnival Corp. (CCL) Tops Q3 EPS by 8c
• DA Davidson Reiterates Buy Rating on MongoDB (MDB) Amid Unexpected CEO Transition
• Wells Fargo: '2027 S7P 500 Index target of 8,600-8,800'